Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

1.2 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 30.15935.62733.18467.95546.9366.88694.91777.24877.999130.101157.54111.067108.764122.162135.80268.81241.40743.777-6.552
Short Term Investments 118.989135.93167.159192.517205.582176.636120.51767.63362.4147.50442.65478.84480.32672.07564.16200013.104
Cash and Short Term Investments 149.148171.557200.343260.472252.512243.522215.434144.881140.409177.605200.194189.911189.09194.237199.96468.81241.40743.7776.552
Net Receivables 0.3760.3980.3190.1060.1890.225000000000.1090.1090.1090.1090
Inventory 0000000000000000000
Other Current Assets 5.4236.3517.2896.3373.132.8683.1644.6573.6232.7242.3661.1423.0084.4244.841.6511.0040.5430
Total Current Assets 154.947178.306207.632266.915255.831246.615218.598149.538144.032180.329202.56191.053192.098198.661204.91370.57242.10344.4296.552
Non-Current Assets:
Property, Plant & Equipment, Net 0.3730.3390.3850.430.470.5030.1250.1650.2180.270.2750.280.2520.0360.0130.006000
Goodwill 0000000000000000000
Intangible Assets 0.056000.184000000000000000
Goodwill and Intangible Assets 0.056000.184000000000000000
Long Term Investments 48.79559.96858.55220.90844.10862.55367.2727.31143.41915.837020.00127.65831.61929.910000
Tax Assets 000-0.184000000000000000
Other Non-Current Assets 0.3070.3790.4060.4760.5580.4540.3780.3910.1950.1510.4290.3440.0790.0140.0132.3650.270-6.552
Total Non-Current Assets 49.53160.68659.34321.99845.13663.5167.77327.86743.83216.2580.70420.62527.98931.66929.9362.3710.270-6.552
Total Assets 204.478238.992266.975288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4290
Liabilities & Equity:
Current Liabilities:
Account Payables 1.0565.6482.3424.2113.0791.3791.3622.0260.7621.642.0841.711.2191.0880.3822.9070.9180.5310
Short Term Debt 0.1380.2660.1290.250.2421.7320.0040.0580.1340.210.2660.2840.278000000
Tax Payables 0000000000000000000
Deferred Revenue 000-0.125000000000000000
Other Current Liabilities 18.12121.82617.44310.9065.1519.864.7326.4477.8835.9624.2633.142.4394.0591.1071.61130.2645.8360
Total Current Liabilities 19.31527.60719.91415.3678.47212.9716.0988.5318.7797.8126.6135.1343.9365.1471.4894.51831.1826.3670
Non-Current Liabilities:
Long Term Debt 28.86229.56929.85928.08927.85127.621000000.050.124000000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 0.780.9701.512.612.5600000-0.025-0.06200174.50456.65356.6530
Total Non-Current Liabilities 29.64229.56929.85929.59930.46130.181000000.0250.06200174.50456.65356.6530
Total Liabilities 48.95757.17649.77344.96638.93343.1526.0988.5318.7797.8126.6135.1593.9985.1471.489179.02287.83563.020
Equity:
Preferred Stock 00000000000000000017.4
Common Stock 0.0060.0060.0060.0060.0060.0060.0060.0040.0040.0040.0040.0040.0040.0040.0040000
Retained Earnings -353.923-325.127-287.973-258.208-237.671-222.798-206.301-193.344-181.734-170.427-157.561-146.851-136.7-127.571-119.222-115.32-53.962-26.9650
Accumulated Other Comprehensive Income/Loss 0.015-0.0480.518-0.164-0.1440.312-0.509-0.646-0.524-0.751-0.965-0.965-0.814-0.231-0.028000-11.42
Other Total Stockholders Equity 509.423506.985504.651502.313499.843489.453487.077362.86361.339359.949355.173354.331353.599352.981352.6069.24165.1538.3740
Total Shareholders Equity 155.521181.816217.202243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089225.183233.36-106.079-45.462-18.5915.98
Total Equity 155.521181.816217.202243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089000005.98
Total Liabilities & Shareholders Equity 204.478238.992266.975288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4295.98